These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21293992)

  • 1. Factors associated with non-adherence to antiretroviral therapy in the SUN study.
    Kyser M; Buchacz K; Bush TJ; Conley LJ; Hammer J; Henry K; Kojic EM; Milam J; Overton ET; Wood KC; Brooks JT
    AIDS Care; 2011 May; 23(5):601-11. PubMed ID: 21293992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.
    Grierson J; Koelmeyer RL; Smith A; Pitts M
    HIV Med; 2011 Oct; 12(9):562-9. PubMed ID: 21554524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder.
    Applebaum AJ; Richardson MA; Brady SM; Brief DJ; Keane TM
    AIDS Behav; 2009 Feb; 13(1):60-5. PubMed ID: 18690532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-infected patients' adherence to highly active antiretroviral therapy: a phenomenological study.
    Mohammadpour A; Yekta ZP; Nikbakht Nasrabadi AR
    Nurs Health Sci; 2010 Dec; 12(4):464-9. PubMed ID: 21210925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to antiretroviral therapy: a survey of factors associated with medication usage.
    Duggan JM; Locher A; Fink B; Okonta C; Chakraborty J
    AIDS Care; 2009 Sep; 21(9):1141-7. PubMed ID: 20024773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic.
    McNabb J; Ross JW; Abriola K; Turley C; Nightingale CH; Nicolau DP
    Clin Infect Dis; 2001 Sep; 33(5):700-5. PubMed ID: 11486292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV.
    Leombruni P; Fassino S; Lavagnino L; Orofino G; Morosini P; Picardi A
    Psychother Psychosom; 2009; 78(4):254-7. PubMed ID: 19468260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting adherence of antiretroviral treatment among AIDS patients in an Ethiopian tertiary university teaching hospital.
    Giday A; Shiferaw W
    Ethiop Med J; 2010 Jul; 48(3):187-94. PubMed ID: 21073079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam.
    Lambers FA; Stolte IG; van den Berg CH; Coutinho RA; Prins M
    Int J Drug Policy; 2011 May; 22(3):210-8. PubMed ID: 21392958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms.
    Webb MS; Vanable PA; Carey MP; Blair DC
    AIDS Educ Prev; 2009 Jun; 21(3 Suppl):94-105. PubMed ID: 19537957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term trends in adherence to antiretroviral therapy from start of HAART.
    Cambiano V; Lampe FC; Rodger AJ; Smith CJ; Geretti AM; Lodwick RK; Puradiredja DI; Johnson M; Swaden L; Phillips AN
    AIDS; 2010 May; 24(8):1153-62. PubMed ID: 20299959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in stress, substance use and medication beliefs are associated with changes in adherence to HIV antiretroviral therapy.
    French T; Tesoriero J; Agins B
    AIDS Behav; 2011 Oct; 15(7):1416-28. PubMed ID: 20640593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The link between religion and HAART adherence in pediatric HIV patients.
    Park J; Nachman S
    AIDS Care; 2010 May; 22(5):556-61. PubMed ID: 20397076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to antiretroviral therapy in pediatric patients with human immunodeficiency virus (HIV-1).
    Burack G; Gaur S; Marone R; Petrova A
    J Pediatr Nurs; 2010 Dec; 25(6):500-4. PubMed ID: 21035017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients.
    Dalessandro M; Conti CM; Gambi F; Falasca K; Doyle R; Conti P; Caciagli F; Fulcheri M; Vecchiet J
    J Clin Psychopharmacol; 2007 Feb; 27(1):58-61. PubMed ID: 17224714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand.
    Ruanjahn G; Roberts D; Monterosso L
    AIDS Care; 2010 Dec; 22(12):1555-61. PubMed ID: 20582752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M; Koffi CK
    AIDS; 2007 Aug; 21(13):1799-803. PubMed ID: 17690579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.